Covered recipient · General Payments record
RICHARD NATTIS
General Payments · PY2018–2024
$3,820.98
- Reported across 144 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $540.58 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $306.89 | 13 |
| Harrow Eye, LLC | $76.92 | 3 |
| BIOTISSUE HOLDINGS INC. | $44.66 | 2 |
| Tarsus Pharmaceuticals, Inc. | $27.08 | 1 |
| Oyster Point Pharma, Inc. | $26.89 | 1 |
| Alcon Laboratories Inc | $21.65 | 1 |
| Ocular Therapeutix, Inc. | $20.30 | 1 |
| Amgen Inc. | $16.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.74 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103967 | CMS |
| ABBVIE INC. | $18.78 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103969 | CMS |
| ABBVIE INC. | $6.57 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103971 | CMS |
| ABBVIE INC. | $15.79 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103973 | CMS |
| ABBVIE INC. | $2.07 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103975 | CMS |
| ABBVIE INC. | $117.25 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103977 | CMS |
| ABBVIE INC. | $22.09 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103979 | CMS |
| ABBVIE INC. | $23.29 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103981 | CMS |
| ABBVIE INC. | $24.30 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103983 | CMS |
| ABBVIE INC. | $2.23 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103985 | CMS |
| ABBVIE INC. | $25.87 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103987 | CMS |
| ABBVIE INC. | $6.76 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103989 | CMS |
| ABBVIE INC. | $28.15 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103991 | CMS |
| Alcon Vision LLC | $21.65 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110599375 | CMS |
| Amgen Inc. | $16.19 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115961468 | CMS |
| BIOTISSUE HOLDINGS INC. | $23.22 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148781143 | CMS |
| BIOTISSUE HOLDINGS INC. | $21.44 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148768802 | CMS |
| Harrow Eye, LLC | $24.43 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145610593 | CMS |
| Harrow Eye, LLC | $26.27 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145610595 | CMS |
| Harrow Eye, LLC | $26.22 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145610597 | CMS |
| Ocular Therapeutix, Inc. | $20.30 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148202755 | CMS |
| Oyster Point Pharma, Inc. | $26.89 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147412730 | CMS |
| Tarsus Pharmaceuticals, Inc. | $27.08 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139119760 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.